Evolutionary inspirations for drug discovery

Trends in Pharmacological Sciences

Volumn 31, Issue 10, 2010, Pages 443-448

  Zhang, Hong Yu ^a   Chen, Ling Ling ^a   Li, Xue Juan ^a   Zhang, Jian ^b  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLAVONOID; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90 INHIBITOR; IDEBENONE; NORPHENAZONE; POLYPHENOL; QUERCETIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VEREGEN;

ANTIBIOTIC RESISTANCE; ANTIOXIDANT ACTIVITY; ARTICLE; DRUG DESIGN; DRUG DEVELOPMENT; DRUG MECHANISM; DRUG TARGETING; EVOLUTION; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING;

ANTIOXIDANTS; BIOLOGICAL EVOLUTION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG DISCOVERY; DRUG INDUSTRY; FLAVONOIDS; FREE RADICAL SCAVENGERS; HISTORY, 19TH CENTURY; HUMANS; PHENOLS;

EID: 77956921528     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2010.07.003     Document Type: Article

References (59)

1. Kaitin K.I. Deconstructing the drug development process: the new face of innovation. Clin. Pharma. Therap. 2010, 87:356-361.
2. Nesse R.M., Williams G.C. Why we get sick: the new science of Darwinian medicine 1994, Times Books, New York.
3. Williams G.C. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957, 11:398-411.
4. Stearns S.C., et al. Evolutionary perspectives on health and medicine. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(suppl. 1):1691-1695.
5. Nesse R.M., et al. Making evolutionary biology a basic science for medicine. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(suppl. 1):1800-1807.
6. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70:461-477.
7. Jones A.M., et al. The impact of Arabidopsis on human health research: " Diversifying our portfolio" Cell 2008, 133:939-943.
8. Taylor L.P., Grotewold E. Flavonoids as developmental regulators. Curr. Opin. Plant Biol. 2005, 8:317-323.
9. Briskin D.P. Medicinal chemicals and phytomedicines. Linking plant biochemistry and physiology to human health. Plant Physiol. 2000, 124:507-514.
10. von Nussbaum F., et al. Antibacterial natural products in medicinal chemistry--exodus or revival?. Angew. Chem. Int. Ed. 2007, 45:5072-5129.
11. Payne D.J., et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 2007, 6:29-40.
12. Fischbach M.A., Walsh C.T. Antibiotics for emerging pathogens. Science 2009, 325:1089-1093.
13. Rutherford S.L. Between genotype and phenotype: protein chaperones and evolvability. Nature Rev. Genet. 2003, 4:263-274.
14. Cowen L.E., Lindquist S. Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 2005, 309:2185-2189.
15. Li Y.Y., et al. New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential. Drug Resist. Updat. 2009, 12:17-27.
16. Cowen L.E., et al. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2818-2823.
17. Tokuriki N., Tawfik D.S. Chaperonin overexpression promotes genetic variation and enzyme evolution. Nature 2009, 459:668-673.
18. Miller C., et al. SOS response induction by ß-lactams and bacterial defense against antibiotic lethality. Science 2004, 305:1629-1631.
19. Cirz R.T., et al. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol. 2005, 3:e176.
20. Lameijer E.W., et al. Evolutionary algorithms in drug design. Nat. Comput. 2005, 4:177-243.
21. Kump L.R. The rise of atmospheric oxygen. Nature 2008, 451:277-278.
22. 2 is required by complex life on habitable planets and the concept of planetary " oxygenation time" Astrobiology 2005, 5:415-438.
23. Raymond J., Segrè D. The effect of oxygen on biochemical networks and the evolution of complex life. Science 2006, 311:1764-1767.
24. 2. Science 2008, 322:540-542.
25. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine 2007, Oxford University Press, New York.
26. Melton L. The antioxidant myth: a medical fairy tale. New Sci. 2006, 190:40-43.
27. Li X.-J., et al. Natural inspirations for antioxidant drug discovery. Drug Discov. Today 2009, 14:910-912.
28. Litwinienko G., Mulder P. Comment on " Temperature and solvent effects on radical scavenging ability of phenols" J. Phys. Chem. A 2009, 113:14014-14016.
29. Zhang H.-Y. Structure-activity relationships and rational design strategies for radical-scavenging antioxidants. Curr. Comput.-Aided Drug Design 2005, 1:257-273.
30. Zhang H.-Y., Ji H.-F. How vitamin E scavenges DPPH radicals in polar protic media. New J. Chem. 2006, 30:503-504.
31. Pun P.B., et al. Ageing in nematodes: do antioxidants extend lifespan in Caenorhabditis elegans?. Biogerontology 2010, 11:17-30.
32. Stanner S.A., et al. A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr. 2004, 7:407-422.
33. Halliwell B., et al. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? antioxidant or not?. Am. J. Clin. Nutr. 2005, 81:268S-276S.
34. Violi F., et al. Antioxidant strategy for cardiovascular disease. Lancet 2001, 357:1704.
35. Gaut J.P., et al. Vitamin C fails to protect amino acids and lipids from oxidation during acute inflammation. Free Radic. Biol. Med. 2006, 40:1494-1501.
36. Shanely R.A., et al. Quercetin supplementation does not alter antioxidant status in humans. Free Radic. Res. 2010, 44:224-231.
37. Korth H.-G. Carbon radicals of low reactivity against oxygen: radically different antioxidants. Angew. Chem. Int. Ed. 2007, 46:5274-5276.
38. Rice-Evans C.A., et al. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20:933-956.
39. Amić D., et al. SAR and QSAR of the antioxidant activity of flavonoids. Curr. Med. Chem. 2007, 14:827-845.
40. Benzie I.F. Evolution of antioxidant defence mechanisms. Eur. J. Nutr. 2000, 39:53-61.
41. Rozema J., et al. The role of UV-B radiation in aquatic and terrestrial ecosystems-an experimental and functional analysis of the evolution of UV-absorbing compounds. J. Photochem. Photobiol. B 2002, 66:2-12.
42. Brown B.A., et al. A UV-B-specific signaling component orchestrates plant UV protection. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18225-18230.
43. Kolb C.A., et al. UV screening by phenolics in berries of grapevine (Vitis vinifera). Funct. Plant Biol. 2003, 30:1177-1186.
44. Kim J.H., et al. Transcriptomic profile of Arabidopsis rosette leaves during the reproductive stage after exposure to ionizing radiation. Radiat. Res. 2007, 168:267-280.
45. Venkateswaran A., et al. Physiologic determinants of radiation resistance in Deinococcus radiodurans. Appl. Environ. Microbiol. 2000, 66:2620-2626.
46. Daly M.J. A new perspective on radiation resistance based on Deinococcus radiodurans. Nat. Rev. Microbiol. 2009, 7:237-245.
47. Zhang H.-Y., et al. Antioxidants used by Deinococcus radiodurans and implications for antioxidant drug discovery. Nat. Rev. Microbiol. 2009, 7:476. 10.1038/nrmicro2073-c1.
48. Gao N., et al. Gene expression analysis of four radiation-resistant bacteria. Genomics Insights 2009, 2:11-22.
49. Gensheimer M., Mushegian A. Chalcone isomerase family and fold: no longer unique to plants. Protein Sci. 2004, 13:540-544.
50. Jiang Z.-D., et al. Actinoflavoside, a novel flavonoid-like glycoside produced by a marine bacterium of the genus Streptomyces. Tetrahedron Lett. 1997, 38:5065-5068.
51. Shen L., et al. How to understand the dichotomy of antioxidants. Biochem. Biophys. Res. Commun. 2007, 362:543-545.
52. Dangles O., et al. Inhibition of lipid peroxidation by quercetin and quercetin derivatives: antioxidant and prooxidant effects. J. Chem. Soc. Perkin Trans. 2000, 2(6):1215-1222.
53. Boots A.W., et al. The quercetin paradox. Toxicol. Appl. Pharmacol. 2007, 222:89-96.
54. Ji H.-F., et al. Natural products and drug discovery. EMBO Rep. 2009, 10:194-200.
55. Middleton E., et al. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52:673-751.
56. Chen L., Zhang H.-Y. Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules 2007, 12:946-957.
57. Spencer J.P. The impact of flavonoids on memory: physiological and molecular considerations. Chem. Soc. Rev. 2009, 38:1152-1161.
58. Crozier A., et al. Dietary phenolics: chemistry, bioavailability and effects on health, Nat. Prod. Rep. 2009, 26:1001-1043.
59. Schmidt B.M., et al. Revisiting the ancient concept of botanical therapeutics. Nat. Chem. Biol. 2007, 3:360-366.